参考文献
[1]WOOD S L, et al.Molecular histology of lung cancer: from targets to treatments[J]. Cancer treatment reviews, 2015.
[2]KOURELIS T V, et al. Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer[J]. Lung cancer 2014.
[3]PARK M R, et al. Progression-free survival: an important prognostic marker for long- term survival of small cell lung cancer[J]. Tuberculosis and respiratory diseases, 2014.
[4]NOVELLO S, et al. Early response to chemotherapy in patientswith non-small-cell lung cancer assessed by [18F]-fluoro-deoxy-D-glucose positron emission tomography and computed tomography[J]. Clinical lung cancer, 2013.
[5]WANGNUM K, et al. Impact of the multidisciplinary education program in self-care on fatigue in lung cancer patients receiving chemotherapy[J]. Journal of the Medical Association of Thailand-Chotmaihet thangphaet, 2013.
[6]FURRUKH M, et al.Individualised Treatment of Metastatic Non-Small-Cell Lung Carcinoma (NSCLC) [J]. Sultan Qaboos University medical journal, 2013.
[7]ULIVI P, et al. Target therapy in NSCLC patients: Relevant clinical agents and tumour molecular characterisation[J]. Molecular and clinical oncology, 2013.
[8]RODRIGUES G, et al.Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial?A multi-institutional propensity score matched analysis[J]. International journal of radiation oncology, biology, physics, 2015.
[9]UNAL D, et al. Is Human Kallikrein 11 in Non-small Cell Lung Cancer Treated Chemoradiotherapy Associated with Survival?[J] Cancer research and treatment : official journal of Korean Cancer Association, 2016.
[10]LE T N, et al.Epigenetic regulation of intragenic transposable elements impacts gene transcription in Arabidopsis thaliana. Nucleic acids research, 2015.
[11]TRIETSCH M D, et al. Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: a review of the current literature[J]. Gynecologic oncology, 2015.
[12]YAMANOI K, et al. Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome[J]. Carcinogenesis, 2015.
[13]CAI S X, et al. Stable genetic alterations of beta-catenin and ROR2 regulate the Wnt pathway, affect the fate of MSCs[J]. Journal of cellular physiology, 2014.
[14]PANDEY M, et al.Involvement of EZH2, SUV39H1, G9a and associated molecules in pathogenesis of urethane induced mouse lung tumors: potential targets for cancer control[J]. Toxicology and applied pharmacology, 2014.
[15]TAO H, et al.Non-coding RNAs as direct and indirect modulators of epigenetic mechanism regulation of cardiac fibrosis[J]. Expert opinion on therapeutic targets, 2015.
[16]ENFIELD K S, et al. Mechanistic Roles of Noncoding RNAs in Lung Cancer Biology and Their Clinical Implications[J]. Genetics research international, 2012.
[17]SHI X, et al. Long non-coding RNAs: a new frontier in the study of human diseases[J]. Cancer letters, 2013.
[18]BILLEREY C, et al. Identification of large intergenic non-coding RNAs in bovine muscle using next-generation transcriptomic sequencing[J]. BMC genomics, 2014.
[19]ECKWAHL M J, et al.A retrovirus packages nascent host noncoding RNAs from a novel surveillance pathway[J]. Genes & development, 2015.
[20]VIERECK J, et al. Long noncoding RNAs as inducers and terminators of vascular development[J]. Circulation, 2015.
[21]LING H, et al. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene, 2015.
[22]KAPRANOV P, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription[J]. Science, 2007.
[23]MARTICK M, et al. A discontinuous hammerhead ribozyme embedded in a mammalian messenger RNA[J]. Nature, 2008.
[24]POLISENO L, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology[J]. Nature, 2010.
[25]MERCER T R, et al.Long non-coding RNAs: insights into functions. Nature reviews. Genetics, 2009.
[26]ZHANG H, et al.Emerging roles of RNA processing factors in regulating long non- coding RNAs[J]. RNA biology, 2014.
[27]ERNST C, et al.Identification and function of long non-coding RNA[J]. Front Cell Neurosci, 2013.
[28]GUTSCHNER T, et al. Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases[J]. Genome research, 2011.
[29]REICHE K, et al. Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein- coding genes[J]. PloS one, 2014.
[30]CHAUMEIL J, et al.Evolution from XIST-independent to XIST-controlled X-chromosome inactivation: epigenetic modifications in distantly related mammals[J]. PloS one, 2011.
[31]LEPOIVRE C, et al. Divergent transcription is associated with promoters of transcriptional regulators[J]. BMC genomics, 2013; 14: 914.
[32]Reis EM, et al. Perspectives of Long Non-Coding RNAs in Cancer Diagnostics[J]. Frontiers in genetics, 2012.
[33]PANZITT K, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA[J]. Gastroenterology, 2007.
[34]TRIPATHI V, et al. Long noncoding RNA MALATI controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB[J]. PLoSgenetics, 2013.
[35]GUPTA R A, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis[J]. Nature, 2010.
[36]LIU Z, et al. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression[J]. PloSone, 2013.
[37]TAKAHASHI H, et al.Widespread genome transcription: new possibilities for RNA therapies[J]. Biochemical and biophysical research communications, 2014.
[38]MORLANDO M, et al. The role of long noncoding RNAs in the epigenetic control of gene expression[J]. ChemMedChem, 2014.
[39]ROSSETTO C C, et al. Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD 14 (+) monocytes and CD34 (+) cells [J]. PLoSpathogens, 2013.